Stay updated on CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.

Latest updates to the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.3.4 is added to the record history, while the previous v3.3.3 entry remains visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the Record History, and the 'HHS Vulnerability Disclosure' footer link plus the previous revision 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check54 days agoChange DetectedA new revision entry v3.3.2 was added to the history and the previous revision v3.2.0 was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the government funding/operational status notice at the top of the page; core study data and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check75 days agoChange DetectedThe history page appears the same overall, with updated Last Update Posted dates and version entries. No study details or outcomes have changed.SummaryDifference0.1%

- Check104 days agoChange DetectedThe page now communicates an updated operating-status notice and a new software version (v3.2.0), replacing the previous version tag (v3.1.0).SummaryDifference12%

Stay in the know with updates to CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.